Mar 15 2013
The March 13, 2013 New England Journal of Medicine released a perspective, Dabigatran and Postmarketing Reports of Bleeding. The authors contend that early reports citing a bleeding rate higher than Coumadin may have been a symptom of intense market vigilance with over-reporting of events. Geo.
Comments (0)
Anticoagulant Therapy
No comments here.